Translational Development Acquisition Corp. (NASDAQ:TDACU) Short Interest Update

Translational Development Acquisition Corp. (NASDAQ:TDACU) was the target of a large growth in short interest in May. As of May 29th, there was short interest totaling 96 shares, a growth of ? from the May 14th total of 0 shares. Based on an average daily trading volume, of 2,588 shares, the days-to-cover ratio is presently 0.0 days.

Translational Development Acquisition Price Performance

Shares of TDACU traded up $0.12 during midday trading on Friday, reaching $11.62. 3,439 shares of the stock were exchanged, compared to its average volume of 4,227. Translational Development Acquisition has a 52 week low of $10.71 and a 52 week high of $17.29. The company’s 50 day moving average is $11.19 and its two-hundred day moving average is $10.72.

Translational Development Acquisition Company Profile

Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.

In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.

Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.